BCR and B-cell chronic lymphocytic leukemia: In previous studies from our group, we have provided evidence that at least a fraction of T cells in patients with CLL may specifically recognize leukemia-associated antigens, with the clonotypic BcR IG expressed by the malignant cells emerging as a potential source of neoepitopes selecting T cells (17, 19, 24).